Rhythm Biosciences Limited (FRA:0RY)
0.0305
-0.0020 (-6.15%)
Last updated: Jul 15, 2025
Rhythm Biosciences Company Description
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia.
It develops ColoSTAT, a blood test for the early detection of colorectal cancer. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.
Rhythm Biosciences Limited
Country | Australia |
Founded | 2017 |
Industry | In Vitro and In Vivo Diagnostic Substances |
CEO | David Atkins |
Contact Details
Address: Bio21 Institute Parkville, 3010 Australia | |
Phone | 61 3 8256 2880 |
Website | rhythmbio.com |
Stock Details
Ticker Symbol | 0RY |
Exchange | Frankfurt Stock Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
David Atkins | Chief Executive Officer |
Todd Perkinson | Chief Financial Officer |